Pleural effusion laboratory findings

Pleural effusion Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pleural Effusion from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiography and Ultrasound
CT Scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Pleural effusion laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pleural effusion laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pleural effusion laboratory findings
CDC on Pleural effusion laboratory findings
Pleural effusion laboratory findings in the news
Blogs on Pleural effusion laboratory findings
Directions to Hospitals Treating Pleural effusion
Risk calculators and risk factors for Pleural effusion laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Laboratory Findings

Once a pleural effusion is diagnosed, the cause must be determined. Pleural fluid is drawn out of the pleural space in a process called thoracentesis. A needle is inserted through the back of the chest wall into the pleural space. The fluid may then be evaluated for the following:

1. Chemical composition including protein, lactate dehydrogenase (LDH), albumin, amylase, pH and glucose
2. Gram stain and culture to identify possible bacterial infections
3. Cell count and differential
4. Cytology to identify cancer cells, but may also identify some infective organisms
5. Other tests as suggested by the clinical situation - lipids, fungal culture, viral culture, specific immunoglobulins

Electrolyte and Biomarker Studies

• Definite diagnoses can be made by specific analyses of fluid.

  • Culture
  • Cytology
  • Lupus erythematosus (LE) cells
  • Antinuclear antibody (ANA) >1 (systemic lupus erythematosus)
  • Amylase and severe acidosis (esophageal rupture)
  • KOH prep
  • Triglycerides (>110mg/dL = chylothorax)
  • Hematocrit (pleural fluid to blood >0.5)
  • Creatinine (urinothorax)
  • Protein <1g/dL
  • Glucose 300 to 400 (peritoneal dialysis).

• Look at the fluid- milky, bloody, clear.
• Transudate

  • Imbalance between hydrostatic and oncotic pressure in chest.
  • May also be movement of fluid from abdominal cavity or retroperitoneal space.

• Exudates:

  • Result from pleural and lung inflammation (resulting in a capillary protein leak) or impaired lymphatic drainage of pleural space (so slow removal of protein from pleural space).
  • Can also result from movement of fluid form peritoneal space.

• If at least one of the following 3 is present, the fluid is virtually always and exudate; in none is present, the fluid is virtually always a transudate:

  • Pleural fluid protein/serum protein ratio >0.5
  • Fluid/serum lactic dehydrogenase (LDH) ratio >0.6
  • Fluid LDH greater than 2/3 the upper limits of normal of the serum LDH

• Some tidbits

  • Tuberculosis (TB) effusions virtually always have a protein above 4.0 g/dL.
  • Pleural fluid protein in the 7 to 8 g/dL range, consider Waldenstrom’s macroglobulinemia and multiple myeloma.
  • LDH avove 1000 usually found in empyema, rheumatoid pleurisy and sometime malignancy.
  • Pleural fluid in Pneumocystis carinii pneumonia (PCP) has fluid/serum LDH greater than 1 and fluid/serum protein ratio less than 0.5.

• Glucose

  • Lower then 60mg/dL or fluid/serum ratio < 0.5 not seen in transudates and limits exudates to the following

    • Rheumatoid pleurisy
    • Parapneumonic effusion or empyema
    • Malignant effusion
    • TB
    • Lupus pleuritis
    • Esophageal rupture.

• pH

  • Less than 7.30 with nrl blood pH found with same diagnosis as low glucose.
  • Normal pleural fluid is around 7.6 due to a bicarbonate gradient between pleural fluid and blood.

• Amylase

  • Greater than the upper limit of normal for serum or a pleural fluid to serum ration >1 narrows an exudate to acute pancreatitis, chronic pancreatic effusion, esophageal rupture or malignancy.

Transudate vs. exudate

The third step in the evaluation of pleural fluid is to determine whether the effusion is a transudate or an exudate. Transudative pleural effusions are caused by systemic factors that alter the balance of the formation and absorption of pleural fluid (e.g., left ventricular failure,pulmonary embolism, and cirrhosis), while exudative pleural effusions are caused by alterations in local factors that influence the formation and absorption of pleural fluid (e.g., bacterial pneumonia, cancer, and viral infection).

Transudative and exudative pleural effusions are differentiated by comparing chemistries in the pleural fluid to those in the blood. According to ameta-analysis, exudative pleural effusions meet at least one of the following criteria :

1. Pleural fluid protein >2.9 g/dL (29 g/L)
2. Pleural fluid cholesterol >45 mg/dL (1.16 mmol/L)
3. Pleural fluid LDH >60 percent of upper limit for serum

Previously criteria proposed by Light for an exudative effusion are met if at least one of the following exists (Light's criteria) :

1. The ratio of pleural fluid protein to serum protein is greater than 0.5
2. The ratio of pleural fluid LDH and serum LDH is greater than 0.6
3. Pleural fluid LDH is more than two-thirds normal upper limit for serum

Twenty-five percent of patients with transudative pleural effusions are mistakenly identified as having exudative pleural effusions by Light's criteria. Therefore, additional testing is needed if a patient identified as having an exudative pleural effusion appears clinically to have a condition that produces a transudative effusion. In such cases albumin levels in blood and pleural fluid are measured. If the difference between the albumin levels in the blood and the pleural fluid is greater than 1.2 g/dL (12 g/L), it can be assumed that the patient has a transudative pleural effusion.

If the fluid is definitively identified as exudative, additional testing is necessary to determine the local factors causing the exudate.

Exudative pleural effusions

Once identified as exudative, additional evaluation is needed to determine the cause of the excess fluid, and pleural fluid amylase, glucose, and cell counts are obtained. The fluid is also sent for Gram staining and culture, and, if suspicious for tuberculosis, examination for TB markers (adenosine deaminase > 45 IU/L, interferon gamma > 140 pg/mL, or positive polymerase chain reaction (PCR) for tuberculous DNA).

Pleural fluid amylase is elevated in cases of esophageal rupture, pancreatic pleural effusion, or cancer. Glucose is decreased with cancer, bacterial infections, or rheumatoid pleuritis. If cancer is suspected, the pleural fluid is sent for cytology. If cytology is negative, and cancer is still suspected, either a thoracoscopy, or needle biopsy of the pleura may be performed.